Sectors
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
ZGT has raised $48m from Tsinghua Holdings Capital, CAS Star and others, while University of Cambridge spinout Colorifix has pocketed $22.7m.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
Baidu Ventures has backed the small molecule cancer therapy developer’s latest round, which came after a slew of healthtech and biotech investments made by the unit in recent months.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
